Molecular Subtyping of Triple Negative Breast Cancer (TNBC): An approach to improving treatment response and survival outcome. mjz [Internet]. 2020 Jan. 8 [cited 2024 Nov. 22];46(3):262-3. Available from: https://mjz.co.zm/index.php/mjz/article/view/234